Type 2 diabetes mellitus is associated with strongyloides stercoralis treatment failure in Australian aboriginals

Objective to explore the efficacy of ivermectin in the treatment of serologically diagnosed cases of strongyloides stercoralis (s. stercoralis) infection in an aboriginal community and to describe factors that may influence the outcome of treatment. methods longitudinal study of a group of 92 individuals with serologically diagnosed s. stercoralis treated with ivermectin and followed up over a period of approximately 6 months. main outcomes were serological titers pre and post treatment,diabetic status,and duration of follow up. findings treatment success was achieved in 62% to 79% of cases dependent on the methods employed for the diagnosis of infection and assessment of treatment outcome. type 2 diabetes mellitus (t2dm) was found to be significantly associated with treatment failure in this group for two of the three methods employed. interpretation ivermectin has been confirmed as an effective treatment for s stercoralis infection in this setting. t2dm appears to be an independent risk factor for treatment failure in this population,and plausible mechanisms to explain this observation are presented. © 2015 hays et al.